Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Moch

Der Pathologe

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Der Pathologe|August 30, 2008
[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer]H Moch
Der Pathologe|September 23, 2011
[Documentation of the diagnostic quality of hospitals: evaluation of autopsy reports]H Moch
Der Pathologe|July 24, 2010
[Cystic renal neoplasms. New entities and molecular findings]H Moch
Der Pathologe|April 23, 2015
[Neuroendocrine tumors of the kidneys]H Moch
Der Pathologe|October 12, 2012
[Renal cancer biomarkers. What is justified?]H Moch
Der Pathologe|August 30, 2008
[Molecular basis of targeted therapy in metastatic renal cancer]H Moch
Der Pathologe|February 18, 2016
[Kidney tumours]H Moch
Der Pathologe|June 9, 2016
[The WHO/ISUP grading system for renal carcinoma]H Moch
Der Pathologe|November 23, 2019
[Eulogy to Prof. Dr. Med. Michael J. Mihatsch : Presentation of the Rudolf Virchow Medal 2019 of the German Society of Pathology]H Moch
Der Pathologe|March 5, 2016
[WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?]H Moch
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Der Pathologe|August 30, 2008
[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer]H Moch
Der Pathologe|September 23, 2011
[Documentation of the diagnostic quality of hospitals: evaluation of autopsy reports]H Moch
Der Pathologe|July 24, 2010
[Cystic renal neoplasms. New entities and molecular findings]H Moch
Der Pathologe|April 23, 2015
[Neuroendocrine tumors of the kidneys]H Moch
Der Pathologe|October 12, 2012
[Renal cancer biomarkers. What is justified?]H Moch
Der Pathologe|August 30, 2008
[Molecular basis of targeted therapy in metastatic renal cancer]H Moch
Der Pathologe|February 18, 2016
[Kidney tumours]H Moch
Der Pathologe|June 9, 2016
[The WHO/ISUP grading system for renal carcinoma]H Moch
Der Pathologe|November 23, 2019
[Eulogy to Prof. Dr. Med. Michael J. Mihatsch : Presentation of the Rudolf Virchow Medal 2019 of the German Society of Pathology]H Moch
Der Pathologe|March 5, 2016
[WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?]H Moch
Pageof 4